Early research (Phase 1)Study completedNCT00970411What this trial is testingStudy of KRN951 in Patients With Solid TumorsWho this might be right forSolid Tumors Kyowa Kirin Co., Ltd. 12
Not applicableStudy completedNCT03669263What this trial is testingA Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in TaiwanWho this might be right forBreakthrough Cancer Pain Chang Gung Memorial Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT05207085What this trial is testingEfficacy of Valbenazine for the Treatment of Trichotillomania in AdultsWho this might be right forTrichotillomania (Hair-Pulling Disorder) Yale University 20
Early research (Phase 1)Study completedNCT02156544What this trial is testingStudy to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519Who this might be right forDyslipidemia Chong Kun Dang Pharmaceutical 41
Early research (Phase 1)Ended earlyNCT01957644What this trial is testingPhase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMMLWho this might be right forMyelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic Boehringer Ingelheim 16
Post-approval studies (Phase 4)Study completedNCT00949884What this trial is testingOlmesartan Comparison to Losartan in Hypertensive SubjectsWho this might be right forHypertension Daiichi Sankyo 941
Early research (Phase 1)Study completedNCT02675478What this trial is testingPhase 1 Study of QuizartinibWho this might be right forRelapsed AMLRefractory AML Daiichi Sankyo Co., Ltd. 17
Very early researchUnknownNCT03673215What this trial is testingThe Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function ImpairmentWho this might be right forLiver Cirrhosis Shenyang Sunshine Pharmaceutical Co., LTD. 58
Early research (Phase 1)Ended earlyNCT02309892What this trial is testingA Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLCWho this might be right forNon-Small Cell Lung Cancer Helix BioPharma Corporation 14
Testing effectiveness (Phase 2)Study completedNCT03516487What this trial is testingSafety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With PhenylketonuriaWho this might be right forPhenylketonuriaHealthy Synlogic 70
Early research (Phase 1)Ended earlyNCT04835714What this trial is testingFind a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS])Who this might be right forSolid Tumors, KRAS Mutation Boehringer Ingelheim 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03833206What this trial is testingA Phase I/II Study of PDC-1421 for Treating Depression in Cancer PatientsWho this might be right forMajor Depressive Disorder BioLite, Inc. 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07173933What this trial is testingPhase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)Who this might be right forWilson Disease GeneCradle Inc 15
Early research (Phase 1)Ended earlyNCT03742349What this trial is testingStudy of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).Who this might be right forTriple Negative Breast Cancer (TNBC) Novartis Pharmaceuticals 64
Early research (Phase 1)Study completedNCT01973244What this trial is testingA Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone DeficiencyWho this might be right forGrowth Hormone DisorderGrowth Hormone Deficiency in Children Novo Nordisk A/S 32
Testing effectiveness (Phase 2)Ended earlyNCT00850993What this trial is testingA Safety and Efficacy Trial of Stannsoporfin in Neonates With HyperbilirubinemiaWho this might be right forHyperbilirubinemia, Neonatal InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company 58
Testing effectiveness (Phase 2)Looking for participantsNCT06695026What this trial is testingEvaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma (HCC) Rznomics, Inc. 45
Early research (Phase 1)Study completedNCT01856634What this trial is testingPharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant TuberculosisWho this might be right forMultidrug Resistant TuberculosisPediatric Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Early research (Phase 1)Study completedNCT03133247What this trial is testingA Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer PatientsWho this might be right forAdvanced Solid Tumors Atridia Pty Ltd. 37
Early research (Phase 1)Active Not RecruitingNCT05614102What this trial is testingA First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bayer 284